{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-007918","form_type":"8-K","ticker":"EDSA","cik":"0001540159","company_name":"Edesa Biotech, Inc.","filed_at":"2025-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.690622+00:00","generated_at":"2026-05-16T13:21:03.917844+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Edesa Biotech increases ATM offering capacity to $2.26M; discloses prior sales of $3.72M","bullets":["Prospectus supplement filed to increase max aggregate offering under ATM to $2,262,508.","Prior sales: $3.72M under Sept 2025 prospectus and $837K under Oct 2024 supplement.","Legal opinion of Fasken Martineau DuMoulin LLP regarding validity of shares attached."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-007918","json":"https://secwatch.observer/filing/0001171843-25-007918.json","markdown":"https://secwatch.observer/filing/0001171843-25-007918.md","text":"https://secwatch.observer/filing/0001171843-25-007918.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325007918/0001171843-25-007918-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325007918/f8k_121225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:21:03.917844+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}